Brief: Corline Biomedical Q4 Net Sales Fall To SEK 2.01 Mln
Feb 17 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q4 NET SALES AMOUNTED TO SEK 2 012 THOUSAND (6 244)
* Q4 THE RESULT AFTER FINANCIAL ITEMS TOTALLED SEK -14,161
THOUSAND (-600)
Source text: ID:nGNE4tKbBj
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln